Sensei Biotherapeutics, Inc. (SNSE) Tops Q2 EPS by 1c

Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) reported Q2 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Sensei Biotherapeutics, Inc. (SNSE) click here.

You May Also Be Interested In

• BTIG Starts Sensei Biotherapeutics (SNSE) at Buy
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters
• Venu Holding enters $250 million at-the-market stock offering agreement